The intestinal mucosa is the primary exposure and entry site of infectious 11 organisms. Tissue-resident memory T cells (Trms) is an important first line of defense 12 against infection in mucosal tissues, their function in intestinal immunization remains 13 to be investigated. Here, we reported that the levels of local mucosal and systemic 14 immune responses were enhanced through oral immunization with H9N2 whole 15 inactivated virus (H9N2 WIV) plus spore. Subsequently, H9N2 WIV plus spore led to 16 the generation of CD103 + CD69 + Trms, which was independent of circulating T cells 17 during the immune period. Meanwhile, we also found that Bacillus subtilis spore can 18 stimulate Acrp30 expression in 3T3-L1 adipocytes. Moreover, adipocyte supernatant 19 or spore also upregulated intercellular adhesion molecule-1 (ICAM-1) expression on 20 dendritic cells (DCs) (P<0.01). Furthermore, the proportion of HA-tetramer + cells was 21 severely curtailed when ICAM-1 expression was suppressed, which was also 22 dependent on HA-loaded DCs. Taken together, our data demonstrated that spore 23 promoted the immune response by stimulating Trms, which were associated with 24 activation of ICAM-1 in DCs.
Spore-adjuvanted immunization induced HA-specific Trms in intestinal tissue
We also investigated antigen-specific Trms after mucosal immunization. To detect 209 whether FTY720 treatment could inhibit lymphocyte circulation, FTY720 was 210 administered to inhibit the circulation of T cells six weeks after the primary 211 vaccination, as illustrated in Figure 4A . In addition, mice were injected i.v. with influenza HA-specific T cells following mucosal immunization were significantly 216 increased in H9N2 WIV plus spore-treated mice and were not altered by FTY720 217 treatment ( Fig. 4C and D) (P < 0.05). Thus, we can speculate that these memory cells 218 also show a bias toward tissue residency. Consistent with the flow cytometry results, 219 we also observed accumulation of influenza HA-specific cells in the intestinal tract, 7 / 23 220 and imaging using microscopy showed that at 5 weeks after oral immunization, 221 allophycocyanin (APC)-tetramer + T cells were readily detectable in the PPs of the 222 ileum ( Fig. 4B ). Together, these results demonstrated that mucosal immunization with 223 H9N2 WIV plus spore can generate influenza-specific T cells in the intestinal tract. 263 Previously, it has been showed that upregulation of ICAM-1 on APC could regulate 8 / 23 264 the generation of central memory cells [31] . According to previous results, we showed 265 that ICAM-1 expression was significantly increased in DCs following spore treatment 266 (10 6 , 10 7 , 10 8 CFU/ml) depending on the concentration ( Fig. 6A and B) (P < 0.01).
ICAM-1 expression on DCs increased after oral spore treatment

267
Moreover, this finding suggested that the effect coincided with the increased levels of 
Spore stimulated Acrp30 expression in 3T3-L1 Adipocytes
292
Since we have demonstrated that spore could enhance the Acrp30 level in intestine 293 ( Fig. 5A ). In order to determine stimulation effects of spore treatment on 294 differentiated 3T3-L1 cells, we performed the induction culture assay of adipocytes. 295 Initially, cells displayed a fibroblast phenotype. Then, cell morphology changed and 296 cells accumulated lipid droplets internally during the process of differentiation. After 297 12 days, when the adipocytes were mature, almost the entire cell volume was stained 298 red by red oil (Fig. 7A ). We subsequently determined the effects of spore on Acrp30 299 protein expression. Spore at 10 6 CFU/ml was sufficient to elicit up-regulation of the 300 Acrp30. Treatment of 10 7 CFU/ml of spore led to a 2-fold increase in the Acrp30 301 protein amount in comparison with the control without spore (Fig. 7B ). The extent of 302 spore-induced increase in protein levels was positively associated with the 303 concentrations of spore, indicating that there is a dose-dependent effect of spore on 304 the increase of adiponectin proteins. We also investigated whether Acrp30 induced by 305 spore could increase ICAM-1 expression on DCs. The cultural supernatant from 306 differentiated 3T3-L1 cells treated by spore or PBS could stimulate the ICAM-1 307 expression on DCs (Fig. 1C and D) . Our data demonstrated that spore effectively with spore treatment, and the treatment of ICAM-1 inhibitor A-205804 suppressed the 331 CD44 + CD69 + phenotype induced by spore ( Fig. 8A and B)(P < 0.01).
332
To assess whether HA-tetramer + specific T cells persisted in the intestine at 6 333 weeks after immunization, antigen-loaded DCs with or without ICAM-1 inhibitor 334 were incubated with IMALs isolated from immunized mice at 37°C for 3 d (Fig. 8D ).
335
Flow cytometric results showed that spore plus H9N2 WIV induced more 336 HA-tetramer + specific cells than H9N2 WIV alone at the present of antigen-pulsed 337 DCs ( Fig. 3E and F) . Taken together, these results indicated that DCs partially require 338 the expression of ICAM-1 for the generation of antigen-specific Trms, which were 339 altered in the presence of ICAM-1 inhibitor added in DCs. Trms precursors with increased expression of CD69 can be isolated from the intestine, 399 which remain the most reliable markers for intestinal-resident T cells in mice [16, 38] .
400
A previous model predicted that ICAM-1 is required to augment the priming process, 
409
To investigate immunological antibodies associated with mucosal responses, we 410 first evaluated antigen-specific antibody production in serum and mucosal fluid. We 12 / 23 411 found that mice immunized with spore plus H9N2 WIV produced more specific IgG 412 in the serum and IgA in the mucosal fluid compared with mice treated with H9N2 413 WIV alone. A similar trend was observed for lymphocyte proliferation after recalling 414 antigens. Furthermore, we demonstrated that SF produced by Bacillus subtilis spore 415 also induced more antibodies through the Th2 response, thus differing from spore. 416 Overall, these findings may reflect a detection limitation in our assays or at least some 417 potential metabolites of Bacillus subtilis spore as active components of mucosal 418 immune enhancement. 419 Here, spore was able to induce a dramatically larger percentage of proliferating containing 1% penicillin and streptomycin). About 2×10 5 cells were seeded on 511 12-well plates and grown to full confluence for 4 days. Then the cells were subjected 512 to the first differentiation medium (DMEM supplemented 10% FBS, 0.5 mM 513 3-isobutyl-1-methylxanthine, 1 µM dexamethasone and 10 µg/ml insulin) starting on 514 day 0 after confluence. After 2 days of induction, the medium was replaced with only 515 insulin in DMEM with 10% FBS for an additional 2 days. Two days later, the cells 516 were grown in regular medium for an additional 8 days and the medium was replaced 517 every 2 days. Isobutyl-1-methylxanthine, dexamethasone and insulin were obtained 518 from Sigma-Aldrich. 3T3-L1 cells were obtained from professor Yang of Nanjing 519 Agriculture University. In this study, the medium was taken from 3T3-L1 adipocytes 520 treated with spore varying from 10 6 and 10 7 CFU/ml for 24 h. Then cell culture 521 supernatant from adipocyte was added to DCs for another 24 h. 522 523 FTY720 treatments and tetramer staining 524 To inhibit circulation of memory T cells, FTY720 (Sigma) 1 mg/kg in PBS was 525 administered intraperitoneally (i.p.), daily for 10 d. In addition, to assess the 526 protective efficacy of the vaccines, the mice were immunized with the same vaccine.
527
Intravascular staining was performed by injecting mice i.v. with FITC-conjugated 528 anti-mouse CD45 antibody (5 μg) for 8-10 min before being euthanized. After 529 immunization and FTY720 treatment, intestinal tissue was collected and collagenase 530 digested, and cells were isolated for flow cytometric analysis as described previously DCs were generated from 4 to 6-week-old C57BL/6 mice using our previous method 541 [48] . Briefly, bone marrow was extracted from the tibias and femurs of C57BL/6 mice 15 / 23 542 with RPMI 1640. Then, the cells were suspended in complete medium (RPMI 1640 543 supplemented with 10% heat-inactivated FBS, 1% PenStrep), 10 ng/ml interleukin-4 544 (IL-4) and granulocyte-macrophage colony-stimulating factor (GM-CSF). After
